X Bioscience PCL SET:XBIO:
Q1 2026 NET LOSS WIDENS TO THB 336.5 MILLION FROM LOSS THB 52.8 MILLION
Q1 2026 REVENUE FROM SALES UP 55.7% TO THB 83 MILLION
X Bioscience Says Q1 2026 Net Loss Widens To THB 336.5 Million From Loss THB 52.8 Million
Earlier from X Bioscience Public
- X Bioscience Appoints Ramjai Sriporaminas As CFO (Acting)
- X Bioscience Pcl's Board Approves Acquisition Of Shares In Hoshi Company
- X Bioscience - Nottapol Thipchatchawanwong Resigns As Chief Financial Officer
- X Bioscience Declares Intention To Acquire Securities For Business Takeover